ClinicalTrials.Veeva

Menu

Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination (Impress)

T

The Alfred

Status

Completed

Conditions

Human Papillomavirus

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02003508
IISP50939

Details and patient eligibility

About

This study will examine how common HPV infection is in teenage males in Australia before and after the introduction of universal school based vaccination of males in Australia.

Full description

Males aged 17 to 19 in Australia will be recruited from 2014. Men will undergo sampling from the penis for HPV. The prevalence of HPV infection will be determined in 2014-2015 and compared to the prevalence in 2016-2017.

Enrollment

345 patients

Sex

Male

Ages

17 to 19 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male
  • Aged 17 to 19
  • Able to complete study requirements
  • Residing in Australia from 12 years of age

Exclusion criteria

-Males reporting sex with males in the past 12 months

Trial design

345 participants in 2 patient groups

Pre-school based vaccination program (not vaccine eligible)
Description:
Young (17-19 years) men who were not eligible for school based vaccination due to their age at the time of the programs roll out.
Post-school based vaccination program (vaccine eligible)
Description:
Young men (17-19 years) who were eligible for school based vaccination due to their age at the time of the programs roll out.

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems